{
  "run": {
    "id": "cmnr13dtf03ayp6588k89ayqt",
    "region": "US",
    "assetId": "cmnr13cht03adp658jw1ytp6u",
    "ticker": "DOC",
    "snapshotId": "cmnr13dgs03app6582176jpjm",
    "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux",
    "createdAt": "2026-04-09T05:20:28.080Z",
    "promptTemplate": {
      "id": "cmnqt07si0005lm3jzpxuu1ux",
      "name": "Oficial 08.apr.2026",
      "version": 1
    },
    "snapshot": {
      "id": "cmnr13dgs03app6582176jpjm",
      "assetId": "cmnr13cht03adp658jw1ytp6u",
      "asOf": "2026-04-08T20:00:02.000Z",
      "snapshot": {
        "asOf": "2026-04-08T20:00:02.000Z",
        "quote": {
          "asOf": "2026-04-08T20:00:02.000Z",
          "open": null,
          "price": 16.68,
          "dayLow": 16.67,
          "volume": 9928219,
          "dayHigh": 17.05,
          "currency": "USD",
          "prevClose": 16.88,
          "week52Low": 15.71,
          "week52High": 19.68
        },
        "fundamentals": {
          "pe": 160.8,
          "beta": 0.69175302852207,
          "epsTTM": 0.1,
          "fcfTTM": null,
          "growth": {
            "epsYoy": -0.7222222222222223,
            "revenueYoy": 0.04520100175933706
          },
          "sector": "Real Estate Investment Trusts",
          "margins": {
            "net": 0.02527783761415363,
            "gross": null,
            "operating": null
          },
          "website": "https://www.healthpeak.com",
          "industry": "Real estate investment trust",
          "pegRatio": -2.22646153846154,
          "ebitdaTTM": 1438804000,
          "forwardPe": 8.73913043478261,
          "marketCap": 9400000000,
          "totalCash": 467457000,
          "totalDebt": 10842893000,
          "debtEquity": 1.44570094721479,
          "quickRatio": null,
          "revenueTTM": 2822512000,
          "companyName": "HEALTHPEAK PROPERTIES, INC.",
          "priceToBook": 1.34804747176466,
          "currentRatio": null,
          "dividendYield": 0.0759453673408123,
          "returnOnAssets": 0.003508405627886443,
          "returnOnEquity": 0.0095128141060632,
          "analystOpinions": null,
          "businessSummary": "Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.",
          "enterpriseValue": 21567534080,
          "analystTargetLow": null,
          "analystTargetHigh": null,
          "analystTargetMean": null,
          "fullTimeEmployees": 387,
          "sharesOutstanding": 695043997,
          "enterpriseToEbitda": 14.9899041704082,
          "analystTargetMedian": null,
          "enterpriseToRevenue": 7.641255052237156,
          "operatingCashflowTTM": 1251959000,
          "analystRecommendationKey": null
        }
      },
      "createdAt": "2026-04-09T05:20:27.629Z"
    },
    "results": [
      {
        "id": "cmnr13dti03b5p6589qtn2qta",
        "runId": "cmnr13dtf03ayp6588k89ayqt",
        "modelId": "anthropic",
        "status": "SUCCESS",
        "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"DOC\",\"currency\":\"USD\",\"current_price\":16.68,\"target_price_6m\":17.80,\"target_price_12m\":18.50,\"recommendation\":\"BUY\",\"confidence\":0.60,\"thesis_bullets\":[\"Healthcare REIT trading near 52-week low with 7.6% dividend yield\",\"Implied P/FFO of ~9x is below healthcare REIT peer average of 12-14x\",\"Merger integration with Physicians Realty Trust driving portfolio diversification\",\"High leverage (debt/equity 1.45) creates refinancing risk if rates stay elevated\",\"Forward P/E of 8.7x signals meaningful earnings recovery expected ahead\"],\"key_drivers\":[{\"driver\":\"Interest rate trajectory impacts REIT valuations and refinancing costs\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Medical office and life science occupancy trends\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Total debt of $10.8B requires ongoing refinancing in uncertain rate environment\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Dividend sustainability supported by $1.25B operating cash flow\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Post-merger synergies from Physicians Realty Trust combination\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Senior housing demographic tailwind from aging population\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"EPS YoY decline of 72% reflects non-cash and merger-related charges\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Healthcare policy and reimbursement changes affecting tenant health\",\"impact\":\"LOW\",\"direction\":\"NEG\"}],\"risks\":[\"Sustained high interest rates compress REIT multiples and raise debt servicing costs\",\"Tenant credit deterioration in healthcare sector reduces occupancy and NOI\",\"Dividend cut risk if FFO/AFFO coverage ratio deteriorates\",\"Life science supply glut in key markets pressures lease rates\",\"Integration risks from Physicians Realty merger weigh on near-term earnings\"],\"assumptions\":{\"revenue_cagr_3y\":0.04,\"ebit_margin_target\":0.32,\"wacc\":0.08,\"terminal_multiple\":12.0},\"scenarios\":{\"bear\":{\"target_price\":14.50,\"prob\":0.20,\"notes\":\"Rates stay elevated, refinancing pressures force deleveraging or dividend cut.\"},\"base\":{\"target_price\":18.50,\"prob\":0.55,\"notes\":\"Gradual rate normalization, stable occupancy, P/FFO re-rates toward 11-12x.\"},\"bull\":{\"target_price\":21.50,\"prob\":0.25,\"notes\":\"Meaningful rate cuts plus accelerating merger synergies drive multiple expansion to 14x FFO.\"}},\"method_notes\":\"REIT-focused valuation using P/FFO (est ~$1.80/sh from OCF/shares) as primary anchor. Current implied P/FFO ~9.3x vs healthcare REIT peer range 12-14x. 12M base target assumes modest re-rating to ~10.3x plus stable FFO. Dividend yield of 7.6% appears covered by OCF (~70% payout). High debt is key offset. Sell-side targets not used as inputs. Not investment advice.\"}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "ai-equity-research-v1",
          "risks": [
            "Sustained high interest rates compress REIT multiples and raise debt servicing costs",
            "Tenant credit deterioration in healthcare sector reduces occupancy and NOI",
            "Dividend cut risk if FFO/AFFO coverage ratio deteriorates",
            "Life science supply glut in key markets pressures lease rates",
            "Integration risks from Physicians Realty merger weigh on near-term earnings"
          ],
          "ticker": "DOC",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.55,
              "notes": "Gradual rate normalization, stable occupancy, P/FFO re-rates toward 11-12x.",
              "target_price": 18.5
            },
            "bear": {
              "prob": 0.2,
              "notes": "Rates stay elevated, refinancing pressures force deleveraging or dividend cut.",
              "target_price": 14.5
            },
            "bull": {
              "prob": 0.25,
              "notes": "Meaningful rate cuts plus accelerating merger synergies drive multiple expansion to 14x FFO.",
              "target_price": 21.5
            }
          },
          "confidence": 0.6,
          "assumptions": {
            "wacc": 0.08,
            "revenue_cagr_3y": 0.04,
            "terminal_multiple": 12,
            "ebit_margin_target": 0.32
          },
          "key_drivers": [
            {
              "driver": "Interest rate trajectory impacts REIT valuations and refinancing costs",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Medical office and life science occupancy trends",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Total debt of $10.8B requires ongoing refinancing in uncertain rate environment",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Dividend sustainability supported by $1.25B operating cash flow",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Post-merger synergies from Physicians Realty Trust combination",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Senior housing demographic tailwind from aging population",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "EPS YoY decline of 72% reflects non-cash and merger-related charges",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Healthcare policy and reimbursement changes affecting tenant health",
              "impact": "LOW",
              "direction": "NEG"
            }
          ],
          "method_notes": "REIT-focused valuation using P/FFO (est ~$1.80/sh from OCF/shares) as primary anchor. Current implied P/FFO ~9.3x vs healthcare REIT peer range 12-14x. 12M base target assumes modest re-rating to ~10.3x plus stable FFO. Dividend yield of 7.6% appears covered by OCF (~70% payout). High debt is key offset. Sell-side targets not used as inputs. Not investment advice.",
          "current_price": 16.68,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Healthcare REIT trading near 52-week low with 7.6% dividend yield",
            "Implied P/FFO of ~9x is below healthcare REIT peer average of 12-14x",
            "Merger integration with Physicians Realty Trust driving portfolio diversification",
            "High leverage (debt/equity 1.45) creates refinancing risk if rates stay elevated",
            "Forward P/E of 8.7x signals meaningful earnings recovery expected ahead"
          ],
          "target_price_6m": 17.8,
          "target_price_12m": 18.5
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "anthropic",
            "webSearch": {
              "enabled": false,
              "maxToolCalls": 2,
              "disabledReason": null
            },
            "pauseTurns": 0,
            "stopReason": "end_turn"
          },
          "sanityIssues": []
        },
        "latencyMs": 44711,
        "createdAt": "2026-04-09T05:20:28.080Z",
        "usage": {
          "inputTokens": 3574,
          "outputTokens": 2152,
          "costUsd": 0.07167
        }
      },
      {
        "id": "cmnr13dti03b8p658v9agfum6",
        "runId": "cmnr13dtf03ayp6588k89ayqt",
        "modelId": "deepseek.reasoner",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"AI Model Recommendation\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"DOC\",\n  \"currency\": \"USD\",\n  \"current_price\": 16.68,\n  \"target_price_6m\": 16.8,\n  \"target_price_12m\": 17.0,\n  \"recommendation\": \"HOLD\",\n  \"confidence\": 0.6,\n  \"thesis_bullets\": [\n    \"Stable healthcare REIT with diversified portfolio.\",\n    \"Moderate revenue growth driven by healthcare demand.\",\n    \"Earnings recovery expected as margins improve.\",\n    \"High dividend yield provides income support.\",\n    \"Valuation near fair value with balanced risks.\"\n  ],\n  \"key_drivers\": [\n    { \"driver\": \"Occupancy rates\", \"impact\": \"HIGH\", \"direction\": \"POS\" },\n    { \"driver\": \"Rental rate growth\", \"impact\": \"MED\", \"direction\": \"POS\" },\n    { \"driver\": \"Interest rate environment\", \"impact\": \"HIGH\", \"direction\": \"NEG\" },\n    { \"driver\": \"Healthcare sector demand\", \"impact\": \"MED\", \"direction\": \"POS\" },\n    { \"driver\": \"Debt management\", \"impact\": \"HIGH\", \"direction\": \"POS\" },\n    { \"driver\": \"Acquisition activity\", \"impact\": \"MED\", \"direction\": \"POS\" },\n    { \"driver\": \"Regulatory changes\", \"impact\": \"LOW\", \"direction\": \"NEG\" }\n  ],\n  \"risks\": [\n    \"Interest rate increases affecting borrowing costs.\",\n    \"Tenant defaults or vacancies.\",\n    \"Economic downturn reducing healthcare spending.\",\n    \"Competition in healthcare real estate.\",\n    \"Regulatory risks in healthcare.\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.045,\n    \"ebit_margin_target\": 0.45,\n    \"wacc\": 0.08,\n    \"terminal_multiple\": 15\n  },\n  \"scenarios\": {\n    \"bear\": { \"target_price\": 15.0, \"prob\": 0.2, \"notes\": \"Interest rates rise sharply, impacting margins.\" },\n    \"base\": { \"target_price\": 17.0, \"prob\": 0.6, \"notes\": \"Steady growth and stable rates.\" },\n    \"bull\": { \"target_price\": 19.0, \"prob\": 0.2, \"notes\": \"Strong occupancy and rental growth.\" }\n  },\n  \"method_notes\": \"Valuation based on earnings recovery and multiple analysis. HOLD due to limited upside. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI Model Recommendation",
          "risks": [
            "Interest rate increases affecting borrowing costs.",
            "Tenant defaults or vacancies.",
            "Economic downturn reducing healthcare spending.",
            "Competition in healthcare real estate.",
            "Regulatory risks in healthcare."
          ],
          "ticker": "DOC",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.6,
              "notes": "Steady growth and stable rates.",
              "target_price": 17
            },
            "bear": {
              "prob": 0.2,
              "notes": "Interest rates rise sharply, impacting margins.",
              "target_price": 15
            },
            "bull": {
              "prob": 0.2,
              "notes": "Strong occupancy and rental growth.",
              "target_price": 19
            }
          },
          "confidence": 0.6,
          "assumptions": {
            "wacc": 0.08,
            "revenue_cagr_3y": 0.045,
            "terminal_multiple": 15,
            "ebit_margin_target": 0.45
          },
          "key_drivers": [
            {
              "driver": "Occupancy rates",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Rental rate growth",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Interest rate environment",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Healthcare sector demand",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Debt management",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Acquisition activity",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Regulatory changes",
              "impact": "LOW",
              "direction": "NEG"
            }
          ],
          "method_notes": "Valuation based on earnings recovery and multiple analysis. HOLD due to limited upside. Not investment advice.",
          "current_price": 16.68,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "Stable healthcare REIT with diversified portfolio.",
            "Moderate revenue growth driven by healthcare demand.",
            "Earnings recovery expected as margins improve.",
            "High dividend yield provides income support.",
            "Valuation near fair value with balanced risks."
          ],
          "target_price_6m": 16.8,
          "target_price_12m": 17
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "endpoint": "https://api.deepseek.com/v1/chat/completions",
            "provider": "deepseek",
            "webSearch": {
              "enabled": false,
              "supported": false
            },
            "responseFormat": "json_object"
          },
          "sanityIssues": []
        },
        "latencyMs": 499,
        "createdAt": "2026-04-09T05:20:28.080Z",
        "usage": {
          "inputTokens": 2083,
          "outputTokens": 5021,
          "costUsd": 0.002692
        }
      },
      {
        "id": "cmnr13dti03b6p658y0w0ejr0",
        "runId": "cmnr13dtf03ayp6588k89ayqt",
        "modelId": "gemini.3-pro",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"Equity Research AI - Healthcare REIT Specialist\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"DOC\",\n  \"currency\": \"USD\",\n  \"current_price\": 16.68,\n  \"target_price_6m\": 17.50,\n  \"target_price_12m\": 18.50,\n  \"recommendation\": \"BUY\",\n  \"confidence\": 0.65,\n  \"thesis_bullets\": [\n    \"Attractive 7.6% dividend yield provides a strong total return floor for investors.\",\n    \"Merger synergies with Physicians Realty Trust enhance scale and operational efficiency.\",\n    \"Resilient medical office portfolio generates stable, long-term cash flows.\",\n    \"Life science segment remains well-positioned for secular biotech industry growth.\",\n    \"Significant valuation discount relative to historical multiples offers a margin of safety.\"\n  ],\n  \"key_drivers\": [\n    {\n      \"driver\": \"Federal Reserve interest rate policy\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Life science lab space occupancy\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Medical office building rent growth\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Merger integration and cost synergies\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Debt refinancing and capital costs\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Biotech venture capital funding levels\",\n      \"impact\": \"LOW\",\n      \"direction\": \"POS\"\n    }\n  ],\n  \"risks\": [\n    \"Sustained high interest rates increasing the cost of capital.\",\n    \"Oversupply of lab space in core life science markets.\",\n    \"Tenant credit risk within the senior housing portfolio.\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 3.5,\n    \"ebit_margin_target\": 32.0,\n    \"wacc\": 7.2,\n    \"terminal_multiple\": 14.0\n  },\n  \"scenarios\": {\n    \"bear\": {\n      \"target_price\": 14.50,\n      \"prob\": 0.25,\n      \"notes\": \"Higher for longer interest rates and lab space oversupply.\"\n    },\n    \"base\": {\n      \"target_price\": 18.50,\n      \"prob\": 0.55,\n      \"notes\": \"Successful merger integration and stable occupancy rates.\"\n    },\n    \"bull\": {\n      \"target_price\": 21.50,\n      \"prob\": 0.20,\n      \"notes\": \"Aggressive rate cuts and accelerated biotech leasing activity.\"\n    }\n  },\n  \"method_notes\": \"Valuation based on a 11x P/FFO multiple applied to 2027 estimates. Recommendation reflects the high dividend yield and merger-driven upside. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "Equity Research AI - Healthcare REIT Specialist",
          "risks": [
            "Sustained high interest rates increasing the cost of capital.",
            "Oversupply of lab space in core life science markets.",
            "Tenant credit risk within the senior housing portfolio."
          ],
          "ticker": "DOC",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.55,
              "notes": "Successful merger integration and stable occupancy rates.",
              "target_price": 18.5
            },
            "bear": {
              "prob": 0.25,
              "notes": "Higher for longer interest rates and lab space oversupply.",
              "target_price": 14.5
            },
            "bull": {
              "prob": 0.2,
              "notes": "Aggressive rate cuts and accelerated biotech leasing activity.",
              "target_price": 21.5
            }
          },
          "confidence": 0.65,
          "assumptions": {
            "wacc": 7.2,
            "revenue_cagr_3y": 3.5,
            "terminal_multiple": 14,
            "ebit_margin_target": 32
          },
          "key_drivers": [
            {
              "driver": "Federal Reserve interest rate policy",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Life science lab space occupancy",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Medical office building rent growth",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Merger integration and cost synergies",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Debt refinancing and capital costs",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Biotech venture capital funding levels",
              "impact": "LOW",
              "direction": "POS"
            }
          ],
          "method_notes": "Valuation based on a 11x P/FFO multiple applied to 2027 estimates. Recommendation reflects the high dividend yield and merger-driven upside. Not investment advice.",
          "current_price": 16.68,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Attractive 7.6% dividend yield provides a strong total return floor for investors.",
            "Merger synergies with Physicians Realty Trust enhance scale and operational efficiency.",
            "Resilient medical office portfolio generates stable, long-term cash flows.",
            "Life science segment remains well-positioned for secular biotech industry growth.",
            "Significant valuation discount relative to historical multiples offers a margin of safety."
          ],
          "target_price_6m": 17.5,
          "target_price_12m": 18.5
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "model": "gemini-3-flash-preview",
            "provider": "gemini",
            "webSearch": {
              "used": false,
              "allowed": false,
              "enabled": false,
              "requested": false,
              "disabledReason": null
            }
          },
          "sanityIssues": []
        },
        "latencyMs": 14367,
        "createdAt": "2026-04-09T05:20:28.080Z",
        "usage": {
          "inputTokens": 2386,
          "outputTokens": 771,
          "costUsd": 0.014024
        }
      },
      {
        "id": "cmnr13dti03b4p658md7acvod",
        "runId": "cmnr13dtf03ayp6588k89ayqt",
        "modelId": "openai.gpt-5.4",
        "status": "SUCCESS",
        "rawOutput": "{\"model\":\"AI Model Recommendation v2\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"DOC\",\"currency\":\"USD\",\"current_price\":16.68,\"target_price_6m\":17.15,\"target_price_12m\":17.55,\"recommendation\":\"HOLD\",\"confidence\":0.64,\"thesis_bullets\":[\"High dividend yield provides valuation support.\",\"Life science and medical office demand remain resilient.\",\"Revenue growth is modest and earnings quality looks mixed.\",\"Leverage is elevated, limiting multiple expansion.\",\"Rate sensitivity caps upside despite defensive property mix.\"],\"key_drivers\":[{\"driver\":\"Interest-rate path\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Life science leasing\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Medical office occupancy\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Debt burden\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Refinancing costs\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Asset dispositions\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Dividend sustainability\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Muted EPS trend\",\"impact\":\"MED\",\"direction\":\"NEG\"}],\"risks\":[\"Higher-for-longer rates compress REIT valuations.\",\"Tenant demand weakens in life science markets.\",\"Refinancing or credit spread pressure hurts cash flow.\",\"Dividend cut would remove key support.\"],\"assumptions\":{\"revenue_cagr_3y\":0.04,\"ebit_margin_target\":0.38,\"wacc\":0.075,\"terminal_multiple\":15},\"scenarios\":{\"bear\":{\"target_price\":15.2,\"prob\":0.25,\"notes\":\"Rates stay elevated and leasing remains soft.\"},\"base\":{\"target_price\":17.55,\"prob\":0.5,\"notes\":\"Stable occupancy and modest growth support current valuation.\"},\"bull\":{\"target_price\":19.8,\"prob\":0.25,\"notes\":\"Lower rates and stronger leasing drive multiple expansion.\"}},\"method_notes\":\"Blended REIT valuation using snapshot fundamentals, dividend support, and EV/EBITDA/NAV-style assumptions; no sell-side targets used. Mixed growth, leverage, and rate sensitivity keep 12M upside below BUY threshold. Snapshot fields kept authoritative; not investment advice.\"}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI Model Recommendation v2",
          "risks": [
            "Higher-for-longer rates compress REIT valuations.",
            "Tenant demand weakens in life science markets.",
            "Refinancing or credit spread pressure hurts cash flow.",
            "Dividend cut would remove key support."
          ],
          "ticker": "DOC",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Stable occupancy and modest growth support current valuation.",
              "target_price": 17.55
            },
            "bear": {
              "prob": 0.25,
              "notes": "Rates stay elevated and leasing remains soft.",
              "target_price": 15.2
            },
            "bull": {
              "prob": 0.25,
              "notes": "Lower rates and stronger leasing drive multiple expansion.",
              "target_price": 19.8
            }
          },
          "confidence": 0.64,
          "assumptions": {
            "wacc": 0.075,
            "revenue_cagr_3y": 0.04,
            "terminal_multiple": 15,
            "ebit_margin_target": 0.38
          },
          "key_drivers": [
            {
              "driver": "Interest-rate path",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Life science leasing",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Medical office occupancy",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Debt burden",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Refinancing costs",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Asset dispositions",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Dividend sustainability",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Muted EPS trend",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "Blended REIT valuation using snapshot fundamentals, dividend support, and EV/EBITDA/NAV-style assumptions; no sell-side targets used. Mixed growth, leverage, and rate sensitivity keep 12M upside below BUY threshold. Snapshot fields kept authoritative; not investment advice.",
          "current_price": 16.68,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "High dividend yield provides valuation support.",
            "Life science and medical office demand remain resilient.",
            "Revenue growth is modest and earnings quality looks mixed.",
            "Leverage is elevated, limiting multiple expansion.",
            "Rate sensitivity caps upside despite defensive property mix."
          ],
          "target_price_6m": 17.15,
          "target_price_12m": 17.55
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "openai",
            "webSearch": {
              "used": false,
              "enabled": false,
              "sources": [],
              "maxToolCalls": 2
            },
            "responseId": "resp_00451e6f7fb07e5d0069d7582e25808193a892ee035bd401d2",
            "reasoningEffort": "medium",
            "structuredOutputs": {
              "used": true,
              "requested": true,
              "disabledReason": null
            }
          },
          "sanityIssues": []
        },
        "latencyMs": 28213,
        "createdAt": "2026-04-09T05:20:28.080Z",
        "usage": {
          "inputTokens": 2353,
          "outputTokens": 1512,
          "costUsd": 0.025286
        }
      },
      {
        "id": "cmnr13dti03b7p658m5r5dui4",
        "runId": "cmnr13dtf03ayp6588k89ayqt",
        "modelId": "xai.grok-4.20-reasoning",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"AI DCF Equity Model\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"DOC\",\n  \"currency\": \"USD\",\n  \"current_price\": 16.68,\n  \"target_price_6m\": 18.0,\n  \"target_price_12m\": 19.5,\n  \"recommendation\": \"BUY\",\n  \"confidence\": 0.62,\n  \"thesis_bullets\": [\n    \"7.6% dividend yield attracts income investors\",\n    \"Life sciences demand supports occupancy growth\",\n    \"Forward P/E of 8.7x signals undervaluation\",\n    \"High debt increases rate sensitivity risks\",\n    \"Demographics favor long-term healthcare REITs\"\n  ],\n  \"key_drivers\": [\n    {\n      \"driver\": \"Aging population demographics\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Interest rate environment\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Life sciences leasing momentum\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Medical office occupancy trends\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Debt refinancing costs\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Healthcare spending growth\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Regulatory reimbursement changes\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Portfolio acquisition pipeline\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    }\n  ],\n  \"risks\": [\n    \"Rising interest rates raise borrowing costs\",\n    \"Occupancy declines in senior housing\",\n    \"Healthcare policy or reimbursement cuts\",\n    \"Economic downturn hits tenant stability\",\n    \"Slower revenue growth than projected\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.045,\n    \"ebit_margin_target\": 0.42,\n    \"wacc\": 0.068,\n    \"terminal_multiple\": 13.5\n  },\n  \"scenarios\": {\n    \"bear\": {\n      \"target_price\": 14.8,\n      \"prob\": 0.3,\n      \"notes\": \"Higher rates and lower occupancy compress multiples.\"\n    },\n    \"base\": {\n      \"target_price\": 19.5,\n      \"prob\": 0.5,\n      \"notes\": \"Stable growth and dividends support modest re-rating.\"\n    },\n    \"bull\": {\n      \"target_price\": 23.0,\n      \"prob\": 0.2,\n      \"notes\": \"Strong life sciences demand drives higher growth and valuation.\"\n    }\n  },\n  \"method_notes\": \"DCF using 4.5% rev CAGR, 42% EBIT margin, 6.8% WACC and 13.5x terminal. 17% 12M upside supports BUY. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI DCF Equity Model",
          "risks": [
            "Rising interest rates raise borrowing costs",
            "Occupancy declines in senior housing",
            "Healthcare policy or reimbursement cuts",
            "Economic downturn hits tenant stability",
            "Slower revenue growth than projected"
          ],
          "ticker": "DOC",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Stable growth and dividends support modest re-rating.",
              "target_price": 19.5
            },
            "bear": {
              "prob": 0.3,
              "notes": "Higher rates and lower occupancy compress multiples.",
              "target_price": 14.8
            },
            "bull": {
              "prob": 0.2,
              "notes": "Strong life sciences demand drives higher growth and valuation.",
              "target_price": 23
            }
          },
          "confidence": 0.62,
          "assumptions": {
            "wacc": 0.068,
            "revenue_cagr_3y": 0.045,
            "terminal_multiple": 13.5,
            "ebit_margin_target": 0.42
          },
          "key_drivers": [
            {
              "driver": "Aging population demographics",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Interest rate environment",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Life sciences leasing momentum",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Medical office occupancy trends",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Debt refinancing costs",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Healthcare spending growth",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Regulatory reimbursement changes",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Portfolio acquisition pipeline",
              "impact": "MED",
              "direction": "POS"
            }
          ],
          "method_notes": "DCF using 4.5% rev CAGR, 42% EBIT margin, 6.8% WACC and 13.5x terminal. 17% 12M upside supports BUY. Not investment advice.",
          "current_price": 16.68,
          "recommendation": "BUY",
          "thesis_bullets": [
            "7.6% dividend yield attracts income investors",
            "Life sciences demand supports occupancy growth",
            "Forward P/E of 8.7x signals undervaluation",
            "High debt increases rate sensitivity risks",
            "Demographics favor long-term healthcare REITs"
          ],
          "target_price_6m": 18,
          "target_price_12m": 19.5
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "xai",
            "webSearch": {
              "used": false,
              "enabled": false,
              "sources": [],
              "maxToolCalls": 2
            },
            "responseId": "3f039c7c-031c-9e96-9ec2-19cfdfab33a9",
            "usedFallbackChatCompletions": false
          },
          "sanityIssues": []
        },
        "latencyMs": 14865,
        "createdAt": "2026-04-09T05:20:28.080Z",
        "usage": {
          "inputTokens": 2691,
          "outputTokens": 2604,
          "costUsd": 0.047133
        }
      }
    ]
  }
}